Phlebology > Volume 23, Number 4 > Pp. 189-192

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Bush, R G Articles by Manjoney, D Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Short Reports

Major neurological events following foam sclerotherapy

R G Bush ^* , M Derrick  and D Manjoney 

^* Midwest Vein and Laser Center, Dayton, OH; Bakersfield Varicose Vein Center, Bakersfield, CA; Wisconsin Vein Center and Medispa, Pewaukee, WI, USA

Correspondence: Ronald G Bush MD FACS, Midwest Vein and Laser Center, 8101 Miller Farm Lane, Dayton, OH 45459, USA. Email: rgb{at}veinaffiliates.com or kandyh{at}midwestveincenters.com

Aim: This report describes two complications of severe neurologic alterations (TIA, CVA) after foamed sclerotherapy injection.

Methods: Using foam sclerotherapy in accepted concentrations, volume, and in standard ratio of air to sclerosant, two serious neurologic complications occurred.

Results: In both cases described, unknown atrial communications existed resulting in foam emboli. One case involving the vertebral system resolved without treatment. The other involving the cerebral system was treated with hyperbaric oxygen.

Conclusions: Foam sclerotherapy can cause serious neurologic phenomenon even though the incidence is rarely described. Immediate treatment with 100% O2 and possible hyperbaric O2 therapy should be considered.

Key Words: foam sclerotherapy • CVA • hyperbaric O2 treatment • air embolus

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P Chapman-Smith and A Browne Prospective five-year study of ultrasound-guided foam sclerotherapy in the treatment of great saphenous vein reflux Phlebology, August 1, 2009; 24(4): 183 - 188. [Abstract] [Full Text] [PDF]

				P. Raymond-Martimbeau Transient adverse events positively associated with patent foramen ovale after ultrasound-guided foam sclerotherapy Phlebology, June 1, 2009; 24(3): 114 - 119. [Abstract] [Full Text] [PDF]

				J-L Gillet, J M Guedes, J-J Guex, C Hamel-Desnos, M Schadeck, M Lauseker, and F A Allaert Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients Phlebology, June 1, 2009; 24(3): 131 - 138. [Abstract] [Full Text] [PDF]

				P C. Smith Foam and liquid sclerotherapy for varicose veins Phlebology, April 1, 2009; 24(suppl_1): 62 - 72. [Abstract] [Full Text] [PDF]